Axsome Therapeutics, Inc. (AXSM)

149.20 -1.48 (-0.98%) USD  |  NASDAQ  |  Dec 30, 12:56
More

Axsome Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade